This page lists the SEC filings reported by Deep Track Capital, LP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | Kura Oncology, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | MADRIGAL PHARMACEUTICALS, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | Magenta Therapeutics, Inc. | 3,000,000 | 5.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | Nkarta, Inc. | 1,354,200 | 2.8% | EDGAR |
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | Nurix Therapeutics, Inc. | 2,266,569 | 4.8% | EDGAR |
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | Nuvation Bio Inc. | 8,221,188 | 3.8% | EDGAR |
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | Passage BIO, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | RELMADA THERAPEUTICS, INC. | 2,837,818 | 9.4% | EDGAR |
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | Repare Therapeutics Inc. | 2,727,606 | 6.5% | EDGAR |
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | Tricida, Inc. | 4,666,666 | 7.4% | EDGAR |
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | Travere Therapeutics, Inc. | 4,582,000 | 7.1% | EDGAR |
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | Viridian Therapeutics, Inc.\DE | 3,312,974 | 7.9% | EDGAR |
| SC 13G | 2023-02-03 | Deep Track Capital, LP | Structure Therapeutics Inc. | 7,940,346 | 7.6% | EDGAR |
| SC 13G | 2023-01-13 | Deep Track Capital, LP | GERON CORP | 24,022,883 | 5.4% | EDGAR |
| SC 13G | 2022-12-22 | Deep Track Capital, LP | Astria Therapeutics, Inc. | 1,816,531 | 7.3% | EDGAR |
| SC 13G | 2022-12-19 | Deep Track Capital, LP | Autolus Therapeutics plc | 15,000,000 | 9.0% | EDGAR |
| SC 13G | 2022-10-28 | Deep Track Capital, LP | Aurinia Pharmaceuticals Inc. | 7,841,570 | 5.5% | EDGAR |
| SC 13G | 2022-10-21 | Deep Track Capital, LP | RELMADA THERAPEUTICS, INC. | 2,481,000 | 8.2% | EDGAR |
| SC 13G | 2022-10-20 | Deep Track Capital, LP | IMMUNIC, INC. | 4,022,989 | 9.3% | EDGAR |
| SC 13G | 2022-10-07 | Deep Track Capital, LP | Valneva SE | 10,513,265 | 7.6% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.